FDA finds little evidence that a drug touted by Trump can help people with autism
Source: AP
By MATTHEW PERRONE
Updated 11:10 AM CDT, March 10, 2026
Leer en español
WASHINGTON (AP) The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back statements by President Donald Trump and other administration officials that the drug showed great promise for people with autism.
The agency said it approved leucovorin for children and adults with a genetic condition that limits delivery of folate, a form of vitamin B, to the brain. FDA officials estimate the ultrarare condition impacts fewer than 1 in a million people in the U.S.
Its a major step back from comments made at a White House news conference in September, when Trump and FDA commissioner Marty Makary announced the drug was under review to benefit patients with autism, some of whom have a form of the vitamin brain deficiency.
It might be 20, 40, 50% of kids with autism, Makary said at the news conference.

Read more: https://apnews.com/article/autism-fda-drug-leucovorin-trump-kennedy-97a1b5092de76b7956f778f374189a0c
generalbetrayus
(1,779 posts)Ray Bruns
(6,249 posts)
twodogsbarking
(18,415 posts)wolfie001
(7,542 posts)👍
ChicagoTeamster
(812 posts)He tried to force the VA to use a PTSD medication despite it's bad performance during trials just because the makers were on some board he created.
wolfie001
(7,542 posts)
TexasBushwhacker
(21,186 posts)that few people have, including people with autism.